Christopher C. Young
Corporate Officer/Principal chez PACIRA BIOSCIENCES, INC.
Profil
Christopher C.
Young currently works at Pacira Biosciences, Inc., as Chief Manufacturing Officer from 2023.
Mr. Young also formerly worked at Akorn, Inc., as Executive Vice President-Global Operations, Actavis, Inc., as Vice President-US Operations, and Alvogen, Inc., as Executive Vice President-Global Operations from 2013 to 2018.
Mr. Young received his undergraduate degree from Gettysburg College and Masters Business Admin degree from Rutgers University, Camden.
Postes actifs de Christopher C. Young
| Sociétés | Poste | Début |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | 19/04/2023 |
Anciens postes connus de Christopher C. Young
| Sociétés | Poste | Fin |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Chief Operating Officer | 01/02/2018 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
| AKORN, INC. | Chief Operating Officer | - |
Formation de Christopher C. Young
| Gettysburg College | Undergraduate Degree |
| Rutgers University, Camden | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
